Coloplast A/S (ETR:CBHD)
Germany · Delayed Price · Currency is EUR 80.80
-1.16 (-1.42%)
Nov 7, 2025, 5:35 PM CET
Coloplast Revenue
In the fiscal year ending September 30, 2025, Coloplast had annual revenue of 27.87B DKK with 3.12% growth. Coloplast had revenue of 6.96B in the quarter ending September 30, 2025, with 0.10% growth.
Revenue
27.87B DKK
Revenue Growth
+3.12%
P/S Ratio
4.88
Revenue / Employee
1.66M DKK
Employees
16,744
Market Cap
18.20B EUR
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 27.87B | 844.00M | 3.12% |
| Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
| Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
| Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
| Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Coloplast News
- 5 days ago - Coloplast A/S (CLPBY) Presents at Fiscal Year 2024/25 CPH roadshow hosted - Slideshow - Seeking Alpha
- 5 days ago - Coloplast A/S (CLPBY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Coloplast Finance B.V. - Annual Report, 2024/25 - GlobeNewsWire
- 5 days ago - Coloplast A/S 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 days ago - Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25 - GlobeNewsWire
- 11 days ago - After A 50% Decline, Coloplast Might Finally Be Worth Buying - Seeking Alpha
- 20 days ago - Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conference call on 4 Nov 2025 at 11.00 CET - GlobeNewsWire
- 4 weeks ago - Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting - GlobeNewsWire